Dr. Thomas Mueller has over 25 years of experience in the pharmaceutical and medical device industry, most recently as director of pharmaceutical development Oncology and API production at Geistlich Pharma AG. He previously held a number of senior positions in the industry, including general manager of Konapharma AG, senior director business development and head chemical development at Siegfried Ltd. and CarboGen Amcis AG. Dr. Mueller’s operating responsibilities encompassed the development and commercialization of products in multiple therapeutic categories including oncology, neurologic, anti-infective, cardiovascular and psychiatric health areas. Dr. Mueller holds a Ph.D. degree in organic chemistry from the University of Constance, Germany, and concluded a postdoctoral fellowship at the Scripps Research Institute in San Diego California. He also earned CAS in Corporate Management at the Institute for Strategy and Business Economics of the University of Zuerich, Switzerland.